ALXO SEC Filings: 8-K, 10-Q, S-3 & 424B – ALX Oncology

Financials

TYPE

HEADLINE

FILED AT

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Aug 6, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

May 8, 2026

10-K

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Mar 9, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Nov 7, 2025

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Aug 12, 2025

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

May 8, 2025

News

TYPE

HEADLINE

FILED AT

8-K

ALX Oncology Holdings Inc. Enters Into Privately-Negotiated Exchange Agreements for Pre-Funded Warrants

Oct 15, 2026

8-K

ALX Oncology Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Aug 6, 2026

8-K

ALX Oncology Appoints Scott Garland as Chairman of the Board and Michael Listgarten as General Counsel

Jun 30, 2026

8-K

ALX Oncology Holdings Inc. Enters into $50 Million Loan and Security Agreement

Jun 26, 2026

8-K

ALX Oncology Holdings Inc. Announces Results of 2026 Annual Meeting of Stockholders

Jun 11, 2026

8-K

ALX Oncology Reports Q1 2026 Financial Results and Positive Clinical Data for Evorpacept

May 8, 2026

Prospectus

TYPE

HEADLINE

FILED AT

424B5

REGISTERED OFFERING

Jan 30, 2026

424B5

7,370,690 Shares of Common Stock

Oct 6, 2023

424B5

Common Stock

Oct 4, 2023

424B3

18,446,936 Shares of Common Stock

Sep 8, 2023

424B5

Common Stock

Aug 25, 2023

424B5

Common Stock-

Dec 17, 2021

Registrations

TYPE

HEADLINE

FILED AT

S-8

Form S-8 - Securities to be offered to employees in employee benefit plans

Jan 21, 2026

S-3

Form S-3 - Registration statement under Securities Act of 1933

Mar 6, 2025

S-8

Form S-8 - Securities to be offered to employees in employee benefit plans

Jan 17, 2025

SC TO-I/A

Form SC TO-I/A - Tender offer statement by Issuer: [Amend]

Dec 31, 2024

SC TO-I

Form SC TO-I - Tender offer statement by Issuer

Dec 2, 2024

S-8

Registration

Mar 7, 2024

Proxies

TYPE

HEADLINE

FILED AT

DEF 14A